#Industry News
Accuray Customers Achieve Top Scores in AAPM MArkerless Lung Target Tracking CHallenge (MATCH) Using Synchrony® Technology on the Radixact® and CyberKnife® Systems
American Association of Physicists in Medicine (AAPM) Grand Challenge MATCH event was designed to evaluate the potential to track lung tumor motion without fiducial markers in real-time during radiation therapy
Accuray Incorporated (NASDAQ: ARAY) announced today that Accuray customers took the top two positions in the MArkerless Lung Target Tracking CHallenge (MATCH) experimental branch using the Accuray Synchrony Lung Tracking with Respiratory Modeling on the Radixact® next-generation TomoTherapy® platform, and CyberKnife® System, respectively. The artificial intelligence (AI)-driven Synchrony technology is unique in using image guidance during radiation treatment delivery to detect motion and automatically adapt and synchronize radiation treatment in real-time with the movement of the target.